Serum Epidermal Growth Factor is Low in Schizophrenia and Not Affected by Antipsychotics Alone or Combined With Electroconvulsive Therapy

Serum Epidermal Growth Factor is Low in Schizophrenia and Not Affected by Antipsychotics Alone or Combined With Electroconvulsive Therapy

BackgroundEpidermal growth factor (EGF) is implicated in the pathogenesis of schizophrenia, suggesting possible value as a biomarker for disease severity or treatment response. However, basal EGF levels and changes during treatment are inconsistent across studies. The goal of this study is to compar...

Full description

Bibliographic Details
Main Authors: Xiaobin Zhang, Wenhuan Xiao, KuanYu Chen, Yaqin Zhao, Fei Ye, Xiaowei Tang, Xiangdong Du
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-03-01
Series:Frontiers in Psychiatry
Subjects:
schizophrenia
epidermal growth factor
electroconvulsive therapy
antipsychotics
clinical response
Online Access:https://www.frontiersin.org/article/10.3389/fpsyt.2020.00104/full

Similar Items

Similar Items